Top Back to top

RACE: A prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for severe aplastic anemia patients

Study number:
8409032
Type of transplant:
 
Short title:
RACE
Study status:
 
Deadline for data collection:
 
Study design:
Open label randomised clinical trial
Primary objective:
To investigate whether Eltrombopag added to standard immunosuppressive treatment increases the rate of early (at three months) complete response in untreated AA patient.
Key inclusion criteria:
≥ 15 years, (very) severe aplastic anemia patients
Country:
France
Germany
Italy
Netherlands
Spain
Switzerland
United Kingdom
Principal investigator:
Antonio Risitano, Regis Peffault de Latour
Principal investigator email:
 
Study coordinator email:
RACEtrial@lumc.nl